Concerns Over Gray-Market Sales of Retatrutide Emerge | Retatrutide News
Unauthorized gray-market sales of Retatrutide have raised safety concerns. The drug is being developed by Eli Lilly for metabolic conditions.
Market News · October 9, 2026
Unauthorized gray-market sales of Retatrutide have raised safety concerns. The drug is being developed by Eli Lilly for metabolic conditions.
Market News · October 9, 2026